{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:28:26Z","timestamp":1792740506264,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":633,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.fertnstert.2020.04.004","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:28:57Z","timestamp":1594718937000},"page":"567-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes"],"prefix":"10.1016","volume":"114","author":[{"suffix":"III","given":"David A.","family":"Schirmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniket D.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Kawwass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheree L.","family":"Boulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitry M.","family":"Kissin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2020.04.004_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","article-title":"Ovarian hyperstimulation syndrome: an update review","volume":"44","author":"Golan","year":"1989","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","article-title":"Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment","volume":"58","author":"Navot","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/humupd\/8.6.559","article-title":"Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review","volume":"8","author":"Delvigne","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001750.pub4","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008605.pub2","article-title":"Cabergoline for preventing ovarian hyperstimulation syndrome","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib6","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/humrep\/14.6.1457","article-title":"Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety","volume":"14","author":"Ferraretti","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002806.pub2","article-title":"Embryo freezing for preventing ovarian hyperstimulation syndrome","author":"d\u2019Angelo","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib8","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0015-0282(99)00090-4","article-title":"Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in\u00a0vitro fertilization","volume":"71","author":"Enskog","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib9","first-page":"611","article-title":"Polycystic ovaries and ovarian hyperstimulation syndrome: a systematic review","volume":"84","author":"Tummon","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib10","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/oxfordjournals.humrep.a138261","article-title":"The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. II. Multiple discriminant analysis for risk prediction","volume":"8","author":"Delvigne","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib11","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.fertnstert.2005.10.052","article-title":"Elevated serum m\u00fcllerian-inhibiting substance may be a marker for ovarian hyperstimulation syndrome in normal women undergoing in\u00a0vitro fertilization","volume":"85","author":"Nakhuda","year":"2006","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1093\/oxfordjournals.humrep.a138260","article-title":"The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features","volume":"8","author":"Delvigne","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0002-9378(88)90523-6","article-title":"Risk factors and prognostic variables in the ovarian hyperstimulation syndrome","volume":"159","author":"Navot","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/oxfordjournals.humrep.a137276","article-title":"Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups","volume":"6","author":"Asch","year":"1991","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib15","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/humupd\/dmg018","article-title":"Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures","volume":"9","author":"Aboulghar","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(94)93001-5","article-title":"Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome","volume":"344","author":"McClure","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/humupd\/dmn008","article-title":"Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome","volume":"14","author":"Soares","year":"2008","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib18","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/humrep\/del005","article-title":"Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome","volume":"21","author":"Pau","year":"2006","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0015-0282(98)00350-1","article-title":"Obstetric outcome of in\u00a0vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study","volume":"70","author":"Abramov","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib20","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/humrep\/deh638","article-title":"Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile","volume":"20","author":"Papanikolaou","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/humrep\/deh713","article-title":"Outcome of pregnancies complicated by severe ovarian hyperstimulation syndrome (OHSS): a follow-up beyond the second trimester","volume":"20","author":"Wiser","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib22","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.fertnstert.2009.05.092","article-title":"Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome","volume":"94","author":"Luke","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib25","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1447-0756.2010.01476.x","article-title":"Impact of grandmultiparity on obstetric outcome in low resource setting","volume":"37","author":"Agrawal","year":"2011","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1515\/JPM.2006.004","article-title":"Does practice make perfect? An age-matched study on grand multiparity in Flanders, Belgium","volume":"34","author":"Jacquemyn","year":"2006","journal-title":"J Perinat Med"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib27","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1097\/01.AOG.0000127426.95464.85","article-title":"Obstetric and neonatal outcomes in grand multiparity","volume":"103","author":"Roman","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/CLEP.S129785","article-title":"Missing data and multiple imputation in clinical epidemiological research","volume":"9","author":"Pedersen","year":"2017","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib29","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s10995-016-1948-6","article-title":"Impact of missing data for body mass index in an epidemiologic study","volume":"20","author":"Razzaghi","year":"2016","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib30","doi-asserted-by":"crossref","first-page":"744","DOI":"10.22237\/jmasm\/1493599140","article-title":"Using multiple imputation to address the inconsistent distribution of a controlling variable when modeling an infrequent outcome","volume":"16","author":"Zhang","year":"2017","journal-title":"J Mod Appl Stat Methods"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jare.2015.01.005","article-title":"GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF\/ICSI treatment cycles: systematic review and meta-analysis","volume":"6","author":"Youssef","year":"2015","journal-title":"J Adv Res"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib32","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1093\/humrep\/dew268","article-title":"A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial","volume":"31","author":"Jacob","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006105.pub3","article-title":"Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome","author":"Tso","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib34","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/humrep\/dey242","article-title":"ART in Europe, 2014: results generated from European registries by ESHRE: the European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE)","volume":"33","author":"de Geyter","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/humrep\/deh129","article-title":"Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE","volume":"19","author":"Nyboe Andersen","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.fertnstert.2018.06.039","article-title":"International Committee for Monitoring Assisted Reproductive Technology: world report on assisted reproductive technology, 2011","volume":"110","author":"Adamson","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.5694\/mja16.01435","article-title":"Assisted reproductive technology in Australia and New Zealand: cumulative live birth rates as measures of success","volume":"207","author":"Chambers","year":"2017","journal-title":"Med J Aust"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib38","series-title":"Assisted reproductive technology surveillance","author":"Kissin","year":"2019"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib39","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in\u00a0vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib40","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib41","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/humrep\/dew051","article-title":"Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF\/ICSI cycles","volume":"31","author":"Toftager","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0015-0282(98)00249-0","article-title":"Serum vascular endothelial growth factor and Doppler blood flow velocities in in\u00a0vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries","volume":"70","author":"Agrawal","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib43","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1542\/peds.111.1.e61","article-title":"US birth weight\/gestational age-specific neonatal mortality: 1995\u20131997 rates for Whites, Hispanics, and Blacks","volume":"111","author":"Alexander","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib44","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ije\/dyq037","article-title":"Neonatal outcome associated with singleton birth at 34\u201341 weeks of gestation","volume":"39","author":"Gouyon","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.fertnstert.2020.04.004_bib45","first-page":"1","article-title":"Infant mortality statistics from the 2013 period linked birth\/infant death data set","volume":"64","author":"Matthews","year":"2015","journal-title":"Natl Vital Stat Rep"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220303320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028220303320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:28:48Z","timestamp":1758011328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028220303320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0015028220303320"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.04.004","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2020.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92020 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}